MedTrace Logo

Study of Application of Transcutaneous Trigeminal Nerve Stimulation and Sound Fusion Stimulation on Tinnitus

NCT05291078 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2023-09-11

No results posted yet for this study

Summary

This study aims to evaluate the efficacy of applying transcutaneous trigeminal nerve stimulation (NUEYNE-T30, NUEYNE-T100) and sound fusion stimulation on tinnitus.

Conditions

  • Tinnitus

Interventions

DEVICE

A transcutaneous trigeminal nerve stimulator: High Frequency

30min/day, at least 5 to 7 times a week

DEVICE

A transcutaneous trigeminal nerve stimulator: Low Frequency

30min/day, at least 5 to 7 times a week

DEVICE

A transcutaneous trigeminal nerve stimulator: Sham

30min/day, at least 5 to 7 times a week

DEVICE

Sound Therapy

Notch Therapy at least 30min/day, at least 5 to 7 times a week

Sponsors & Collaborators

  • Nu Eyne Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Iljoon Moon, Ph. D., MD. · Department of Otorhinolaryngology, Samsung Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-22
Primary Completion
2021-05-18
Completion
2021-05-18

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05291078 on ClinicalTrials.gov